Literature DB >> 23813468

Correlations of noninvasive BOLD and TOLD MRI with pO2 and relevance to tumor radiation response.

Rami R Hallac1, Heling Zhou, Rajesh Pidikiti, Kwang Song, Strahinja Stojadinovic, Dawen Zhao, Timothy Solberg, Peter Peschke, Ralph P Mason.   

Abstract

PURPOSE: To examine the potential use of blood oxygenation level dependent (BOLD) and tissue oxygenation level dependent (TOLD) contrast MRI to assess tumor oxygenation and predict radiation response.
METHODS: BOLD and TOLD MRI were performed on Dunning R3327-AT1 rat prostate tumors during hyperoxic gas breathing challenge at 4.7 T. Animals were divided into two groups. In Group 1 (n = 9), subsequent (19) F MRI based on spin lattice relaxation of hexafluorobenzene reporter molecule provided quantitative oximetry for comparison. For Group 2 rats (n = 13) growth delay following a single dose of 30 Gy was compared with preirradiation BOLD and TOLD assessments.
RESULTS: Oxygen (100%O2 ) and carbogen (95%O2 /5%CO2 ) challenge elicited similar BOLD, TOLD and pO2 responses. Strong correlations were observed between BOLD or R2* response and quantitative (19) F pO2 measurements. TOLD response showed a general trend with weaker correlation. Irradiation caused a significant tumor growth delay and tumors with larger changes in TOLD and R1 values upon oxygen breathing exhibited significantly increased tumor growth delay.
CONCLUSION: These results provide further insight into the relationships between oxygen sensitive (BOLD/TOLD) MRI and tumor pO2 . Moreover, a larger increase in R1 response to hyperoxic gas challenge coincided with greater tumor growth delay following irradiation.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  BOLD; MRI; carbogen; hypoxia; oximetry; oxygen; radiation response

Mesh:

Substances:

Year:  2013        PMID: 23813468      PMCID: PMC3883977          DOI: 10.1002/mrm.24846

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  55 in total

1.  Stereotactic body radiation therapy for inoperable early stage lung cancer.

Authors:  Robert Timmerman; Rebecca Paulus; James Galvin; Jeffrey Michalski; William Straube; Jeffrey Bradley; Achilles Fakiris; Andrea Bezjak; Gregory Videtic; David Johnstone; Jack Fowler; Elizabeth Gore; Hak Choy
Journal:  JAMA       Date:  2010-03-17       Impact factor: 56.272

Review 2.  Hypoxia: importance in tumor biology, noninvasive measurement by imaging, and value of its measurement in the management of cancer therapy.

Authors:  James L Tatum; Gary J Kelloff; Robert J Gillies; Jeffrey M Arbeit; J Martin Brown; K S Clifford Chao; J Donald Chapman; William C Eckelman; Anthony W Fyles; Amato J Giaccia; Richard P Hill; Cameron J Koch; Murali Cherukuri Krishna; Kenneth A Krohn; Jason S Lewis; Ralph P Mason; Giovanni Melillo; Anwar R Padhani; Garth Powis; Joseph G Rajendran; Richard Reba; Simon P Robinson; Gregg L Semenza; Harold M Swartz; Peter Vaupel; David Yang; Barbara Croft; John Hoffman; Guoying Liu; Helen Stone; Daniel Sullivan
Journal:  Int J Radiat Biol       Date:  2006-10       Impact factor: 2.694

3.  Tumor oximetry: demonstration of an enhanced dynamic mapping procedure using fluorine-19 echo planar magnetic resonance imaging in the Dunning prostate R3327-AT1 rat tumor.

Authors:  S Hunjan; D Zhao; A Constantinescu; E W Hahn; P P Antich; R P Mason
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-03-15       Impact factor: 7.038

4.  Intracranial tumor response to respiratory challenges at 3.0 T: impact of different methods to quantify changes in the MR relaxation rate R2*.

Authors:  Andreas Müller; Stefanie Remmele; Ingobert Wenningmann; Hans Clusmann; Frank Träber; Sebastian Flacke; Roy König; Jürgen Gieseke; Winfried A Willinek; Hans H Schild; Petra Mürtz
Journal:  J Magn Reson Imaging       Date:  2010-07       Impact factor: 4.813

5.  Stereotactic ablative radiotherapy should be combined with a hypoxic cell radiosensitizer.

Authors:  J Martin Brown; Maximilian Diehn; Billy W Loo
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-01       Impact factor: 7.038

6.  Relative biological effectiveness of carbon ions for local tumor control of a radioresistant prostate carcinoma in the rat.

Authors:  Peter Peschke; Christian P Karger; Michael Scholz; Jürgen Debus; Peter E Huber
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-08       Impact factor: 7.038

7.  In vivo 19F magnetic resonance spectroscopy and chemical shift imaging of tri-fluoro-nitroimidazole as a potential hypoxia reporter in solid tumors.

Authors:  Daniel Procissi; Filip Claus; Paul Burgman; Jacek Koziorowski; J Donald Chapman; Sunitha B Thakur; Cornelia Matei; C Clifton Ling; Jason A Koutcher
Journal:  Clin Cancer Res       Date:  2007-06-15       Impact factor: 12.531

8.  Tumor oxygen dynamics: correlation of in vivo MRI with histological findings.

Authors:  Dawen Zhao; Sophia Ran; Anca Constantinescu; Eric W Hahn; Ralph P Mason
Journal:  Neoplasia       Date:  2003 Jul-Aug       Impact factor: 5.715

9.  Tumor oxygen dynamics with respect to growth and respiratory challenge: investigation of the Dunning prostate R3327-HI tumor.

Authors:  D Zhao; A Constantinescu; E W Hahn; R P Mason
Journal:  Radiat Res       Date:  2001-11       Impact factor: 2.841

10.  Enhancement of relaxation rate with paramagnetic contrast agents in NMR imaging.

Authors:  I R Young; G J Clarke; D R Bailes; J M Pennock; F H Doyle; G M Bydder
Journal:  J Comput Tomogr       Date:  1981-12
View more
  57 in total

Review 1.  Imaging radiation response in tumor and normal tissue.

Authors:  Marjan Rafat; Rehan Ali; Edward E Graves
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-06-15

2.  In Vivo Chemiluminescent Imaging Agents for Nitroreductase and Tissue Oxygenation.

Authors:  Jian Cao; James Campbell; Li Liu; Ralph P Mason; Alexander R Lippert
Journal:  Anal Chem       Date:  2016-04-15       Impact factor: 6.986

3.  O2 -sensitive MRI distinguishes brain tumor versus radiation necrosis in murine models.

Authors:  Scott C Beeman; Ying-Bo Shui; Carlos J Perez-Torres; John A Engelbach; Joseph J H Ackerman; Joel R Garbow
Journal:  Magn Reson Med       Date:  2015-07-14       Impact factor: 4.668

4.  Assessment of response to anti-angiogenic targeted therapy in pulmonary metastatic renal cell carcinoma: R2* value as a predictive biomarker.

Authors:  Guangyu Wu; Guiqin Liu; Wen Kong; Jianxun Qu; Shiteng Suo; Xiaosheng Liu; Jianrong Xu; Jin Zhang
Journal:  Eur Radiol       Date:  2017-01-27       Impact factor: 5.315

5.  The effect of flow on blood oxygen level dependent (R* 2 ) MRI of orthotopic lung tumors.

Authors:  Heling Zhou; Olivier Belzile; Zhang Zhang; Jo Wagner; Chul Ahn; James A Richardson; Debabrata Saha; Rolf A Brekken; Ralph P Mason
Journal:  Magn Reson Med       Date:  2019-01-30       Impact factor: 4.668

Review 6.  Translating preclinical MRI methods to clinical oncology.

Authors:  David A Hormuth; Anna G Sorace; John Virostko; Richard G Abramson; Zaver M Bhujwalla; Pedro Enriquez-Navas; Robert Gillies; John D Hazle; Ralph P Mason; C Chad Quarles; Jared A Weis; Jennifer G Whisenant; Junzhong Xu; Thomas E Yankeelov
Journal:  J Magn Reson Imaging       Date:  2019-03-29       Impact factor: 4.813

Review 7.  Imaging tumor hypoxia to advance radiation oncology.

Authors:  Chen-Ting Lee; Mary-Keara Boss; Mark W Dewhirst
Journal:  Antioxid Redox Signal       Date:  2014-03-24       Impact factor: 8.401

Review 8.  Imaging tumour hypoxia with oxygen-enhanced MRI and BOLD MRI.

Authors:  James P B O'Connor; Simon P Robinson; John C Waterton
Journal:  Br J Radiol       Date:  2019-01-24       Impact factor: 3.039

9.  Oxygen-induced leakage of spin polarization in Overhauser-enhanced magnetic resonance imaging: Application for oximetry in tumors.

Authors:  Artem A Gorodetskii; Timothy D Eubank; Benoit Driesschaert; Martin Poncelet; Emily Ellis; Valery V Khramtsov; Andrey A Bobko
Journal:  J Magn Reson       Date:  2018-10-10       Impact factor: 2.229

Review 10.  Magnetic resonance imaging of the tumor microenvironment in radiotherapy: perfusion, hypoxia, and metabolism.

Authors:  Masayuki Matsuo; Shingo Matsumoto; James B Mitchell; Murali C Krishna; Kevin Camphausen
Journal:  Semin Radiat Oncol       Date:  2014-07       Impact factor: 5.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.